• Mashup Score: 0
    Europe PMC - 2 year(s) ago

    Europe PMC is an archive of life sciences journal literature.

    Source: europepmc.org
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Almanfi_Cardio
      Almanfi_Cardio

      Great study from UK registry on #TAVR durability: ------------- 1- Excellent Hemodynamic data remains stable up to more than 10 years post-TAVI. 2- Severe SVD occurred in 5.9% 3-Valve-related death/reintervention in 2.3%. 4- Severe SVD was more https://t.co/hkc7AUK9FT… https://t.co/JTtmEKzWVv

  • Mashup Score: 1
    Dr. Almanfi's Cardiovascular Channel - 2 year(s) ago

    Dr. Almanfi is triple board certified interventional cardiologist, Structural heart & Endovascular consultant. Graduated from Al-Arab Medical university in Benghazi Libya & He is a fellowship trained at the Texas Heart Institute THI, Baylor College Of Medicine, Houston Texas. He is sub-specialized in managing various complex cardiac and vascular conditions using minimally invasive technologies…

    Source: YouTube
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Almanfi_Cardio
      Almanfi_Cardio

      Just joined the 100 subscribers on YouTube club. VIRTUAL HIGH-FIVE! https://t.co/pQ7yQdsOCs

  • Mashup Score: 0
    Dr. Almanfi's Cardiovascular Channel Trailer - 2 year(s) ago

    Hi, I’m Dr. Almanfi. I’m a board certified interventional cardiologist and structural heart consultant. I am practicing currently in Houston Texas USA. I am…

    Source: YouTube
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Almanfi_Cardio
      Almanfi_Cardio

      Glad to launch my CardioVascular educational YouTube channel .. I will be sharing and discussing the latest in the field of interventional cardiology, endovascular and structural heart cases and updates. Welcome to subscribe! ---------- Dr. Almanfi's https://t.co/cxxKDPIugr… https://t.co/jvGz7Z2yhu

  • Mashup Score: 0
    Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement - 2 year(s) ago

    December 13, 2022 — Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company’s EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes. The data were presented during the late-breaking trials session at PCR London…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Almanfi_Cardio
      Almanfi_Cardio

      EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes. One-year Data .. https://t.co/eXtLByR8Qu

  • Mashup Score: 3
    Severe prosthesis-patient mismatch after TAVR linked to a higher risk of death - 2 year(s) ago

    Severe prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) is associated with a consistently higher risk of death, according to new findings published in JACC: Cardiovascular Imaging.[1] This is not the case, however, with moderate PPM after TAVR. The study’s authors noted that surgical aortic valve replacement (SAVR) is known to make a significant impact on…

    Source: Cardiovascular Business
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Almanfi_Cardio
      Almanfi_Cardio

      Severe prosthesis-patient mismatch PPM after TAVR linked to a higher risk of death https://t.co/fBkzWivlQl

Load More